Target intelligence / Profile preview

TBC1 domain family member 24 (TBC1D24)

Target
TBC1D24
Molecular classification
Other (Rab-GAP family, membrane trafficking regulator), Signaling protein, TBC domain-containing protein
01

Overview

TBC1 domain family member 24 (TBC1D24) encodes a cytosolic protein highly expressed in the brain and involved in vesicular transport, especially in neurons. It contains a TBC domain (related to Rab-GTPase activating proteins, although most studies indicate it lacks RabGAP activity) and a TLDc domain of unknown function. TBC1D24 interacts with the small GTPase ARF6, involved in regulating membrane trafficking and synaptic vesicle exchange, and participates in neuronal migration, polarity, and maturation. Pathogenic mutations in TBC1D24 disrupt its interactions and functions, resulting in a spectrum of neurological disorders, including early-onset epilepsies, intellectual disability, DOORS syndrome, and forms of inherited sensorineural deafness. The protein is also active in the inner ear's stereocilia, vital for auditory processes. There are currently no drugs specifically targeting TBC1D24, and therapy for associated conditions is symptomatic and supportive. Detection of TBC1D24 mutations is a genetic biomarker for several rare disorders.

Other names
TBC1D24KIAA1171TLDC6Deafness, autosomal dominant 65DOORS syndrome geneSkywalker homolog (Drosophila)DFNB86DFNA65EIEE16 (Epileptic Encephalopathy)DEE16TBC/LysM-associated domain containing 6
02

Biological functions

Vesicle trafficking (membrane transport)Regulation of synaptic vesicle dynamicsNeuronal migration and maturationResponse to oxidative stress
03

Disease associations

Epilepsy (various autosomal recessive and dominant forms)DOORS syndrome (deafness, nail abnormalities, osteodystrophy, developmental delay, seizures)Intellectual disabilityDeafness (sensorineural)Early infantile epileptic encephalopathy (EIEE16)Neurodevelopmental disorders
04

Biomarkers

TBC1D24 gene mutations (biomarker for genetic diagnosis in DOORS syndrome, epilepsy, deafness, etc.)

Beyond the preview

Go deeper on TBC1 domain family member 24 (TBC1D24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TBC1 domain family member 24 (TBC1D24).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call